Global Drug Discovery Technologies Market Professional Survey Report 2019

2 Global Drug Discovery Technologies Quarterly Market Size Analysis

• 2.1 Drug Discovery Technologies Business Impact Assessment - COVID-19
  • 2.1.1 Global Drug Discovery Technologies Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Drug Discovery Technologies Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 By Players, Global Drug Discovery Technologies Quarterly Market Size, 2019 VS 2020
• 3.2 By Players, Drug Discovery Technologies Headquarters and Area Served
• 3.3 Date of Key Players Enter into Drug Discovery Technologies Market
• 3.4 Key Players Drug Discovery Technologies Product Offered
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Drug Discovery Technologies Segments, By Type

• 4.1 Introduction
  • 1.4.1 Biochips
  • 1.4.2 High throughput screening
  • 1.4.3 Pharmacogenomics
  • 1.4.4 Genomics
  • 1.4.5 Bioanalytical instruments
  • 1.4.6 Bioinformatics
  • 1.4.7 Nanotechnology
  • 1.4.8 Others
• 4.2 By Type, Global Drug Discovery Technologies Market Size, 2019-2021

5 Impact of Covid-19 on Drug Discovery Technologies Segments, By Application

• 5.1 Overview
  • 5.5.1 Biopharmaceutical companies
  • 5.5.2 Pharmaceutical companies
  • 5.5.3 Research institutes
  • 5.5.4 Biotech companies
• 5.2 By Application, Global Drug Discovery Technologies Market Size, 2019-2021
  • 5.2.1 By Application, Global Drug Discovery Technologies Market Size by Application, 2019-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Agilent Technologies, Inc
  • 7.1.1 Agilent Technologies, Inc Business Overview
  • 7.1.2 Agilent Technologies, Inc Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.1.3 Agilent Technologies, Inc Drug Discovery Technologies Product Introduction
  • 7.1.4 Agilent Technologies, Inc Response to COVID-19 and Related Developments
• 7.2 Abbott Laboratories, Inc.
  • 7.2.1 Abbott Laboratories, Inc. Business Overview
  • 7.2.2 Abbott Laboratories, Inc. Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.2.3 Abbott Laboratories, Inc. Drug Discovery Technologies Product Introduction
  • 7.2.4 Abbott Laboratories, Inc. Response to COVID-19 and Related Developments
• 7.3 GE Healthcare Ltd.
  • 7.3.1 GE Healthcare Ltd. Business Overview
  • 7.3.2 GE Healthcare Ltd. Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.3.3 GE Healthcare Ltd. Drug Discovery Technologies Product Introduction
  • 7.3.4 GE Healthcare Ltd. Response to COVID-19 and Related Developments
• 7.4 Albany Molecular Research Inc.
  • 7.4.1 Albany Molecular Research Inc. Business Overview
  • 7.4.2 Albany Molecular Research Inc. Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.4.3 Albany Molecular Research Inc. Drug Discovery Technologies Product Introduction
  • 7.4.4 Albany Molecular Research Inc. Response to COVID-19 and Related Developments
• 7.5 Affymetrix Inc.
  • 7.5.1 Affymetrix Inc. Business Overview
  • 7.5.2 Affymetrix Inc. Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.5.3 Affymetrix Inc. Drug Discovery Technologies Product Introduction
  • 7.5.4 Affymetrix Inc. Response to COVID-19 and Related Developments
• 7.6 Arqule Inc.
  • 7.6.1 Arqule Inc. Business Overview
  • 7.6.2 Arqule Inc. Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.6.3 Arqule Inc. Drug Discovery Technologies Product Introduction
  • 7.6.4 Arqule Inc. Response to COVID-19 and Related Developments
• 7.7 Luminex Corporation
  • 7.7.1 Luminex Corporation Business Overview
  • 7.7.2 Luminex Corporation Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.7.3 Luminex Corporation Drug Discovery Technologies Product Introduction
  • 7.7.4 Luminex Corporation Response to COVID-19 and Related Developments
• 7.8 Bayer Healthcare AG
  • 7.8.1 Bayer Healthcare AG Business Overview
  • 7.8.2 Bayer Healthcare AG Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.8.3 Bayer Healthcare AG Drug Discovery Technologies Product Introduction
  • 7.8.4 Bayer Healthcare AG Response to COVID-19 and Related Developments
• 7.9 Novartis AG
  • 7.9.1 Novartis AG Business Overview
  • 7.9.2 Novartis AG Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.9.3 Novartis AG Drug Discovery Technologies Product Introduction
  • 7.9.4 Novartis AG Response to COVID-19 and Related Developments
• 7.10 Astrazeneca plc
  • 7.10.1 Astrazeneca plc Business Overview
  • 7.10.2 Astrazeneca plc Drug Discovery Technologies Quarterly Revenue, 2020
  • 7.10.3 Astrazeneca plc Drug Discovery Technologies Product Introduction
  • 7.10.4 Astrazeneca plc Response to COVID-19 and Related Developments

8 Key Findings

9 Appendix

• 9.1 About US